Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
ArriVent BioPharma, Inc. (AVBP) Ownership - Who Owns ArriVent BioPharma, Inc.?
16 Followers
ArriVent BioPharma, Inc. (AVBP) Ownership Overview
27.49% Insiders
8.68% Mutual Funds
3.52% Other Institutional Investors
60.31% Public Companies and
Individual Investors
The ownership structure of ArriVent BioPharma, Inc. (AVBP) stock is a mix of institutional, retail and individual investors. Approximately 12.20% of the company’s stock is owned by Institutional Investors, 27.49% is owned by Insiders and 60.31% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 01, 2024 | Hillhouse Capital Management, Ltd. >10% Owner | xxxxxxxxxxxxx | $9999990 |
| Jan 31, 2024 | Orbimed Advisors Llc Director, >10% Owner | xxxxxxxxxxxxx | $7999992 |
| Jan 31, 2024 | Carl Gordon Director, >10% Owner | xxxxxxxxxxxxx | $7999992 |
| Jan 31, 2024 | James Healy Director | xxxxxxxxxxxxx | $7999992 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $446500 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1786000 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $2710576 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $7411900 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,950,000 | Institution | 5.82% | 43,641,000 | |
| 619,117 | Institution | 1.85% | 13,855,838 | |
| 573,842 | Institution | 1.71% | 12,842,584 | |
| 415,000 | Institution | 1.24% | 9,287,700 | |
| 382,373 | Institution | 1.14% | 8,557,508 | |
| 151,768 | Institution | 0.45% | 3,396,568 | |
| 105,711 | Institution | 0.32% | 2,365,812 | |
| 104,217 | Institution | 0.31% | 2,332,376 | |
| 100,000 | Institution | 0.30% | 2,238,000 | |
| 83,000 | Institution | 0.25% | 1,857,540 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,950,000 | Institution | 5.82% | 43,641,000 | |
| 573,842 | Institution | 1.71% | 12,842,584 | |
| 105,711 | Institution | 0.32% | 2,365,812 | |
| 104,217 | Institution | 0.31% | 2,332,376 | |
| 83,000 | Institution | 0.25% | 1,857,540 | |
| 44,676 | Institution | 0.13% | 999,849 | |
| 12,932 | Institution | 0.04% | 289,418 | |
| 8,443 | Institution | 0.03% | 188,954 | |
| 7,689 | Institution | 0.02% | 172,080 | |
| 4,300 | Institution | 0.01% | 96,234 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 411,002 | Institution | 1.23% | 7,624,087 | |
| 268,218 | Institution | 0.80% | 6,002,719 | |
| 162,840 | Institution | 0.49% | 3,020,682 | |
| 53,546 | Institution | 0.16% | 1,198,359 | |
| 50,196 | Institution | 0.15% | 1,061,143 | |
| 37,889 | Institution | 0.11% | 847,956 | |
| 36,543 | Institution | 0.11% | 677,873 | |
| 26,139 | Institution | 0.08% | 584,991 | |
| 22,252 | Institution | 0.07% | 498,000 | |
| 5,972 | Institution | 0.02% | 126,248 |
FAQ
Who Owns ArriVent BioPharma, Inc. (AVBP)?
According to the latest TipRanks data, approximately 3.52% of the company's stock is held by institutional investors, 27.49% is held by insiders, and 60.31% is held by retail investors.
What percentage of ArriVent BioPharma, Inc. (AVBP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.52% of ArriVent BioPharma, Inc. (AVBP) stock is held by institutional investors.
What percentage of ArriVent BioPharma, Inc. (AVBP) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.31% of ArriVent BioPharma, Inc. (AVBP) stock is held by retail investors.
Who owns the most shares of ArriVent BioPharma, Inc. (AVBP)?
Fidelity Select Portfolios owns the most shares of ArriVent BioPharma, Inc. (AVBP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.